NexImmune Inc. (NEXI)
OTC: NEXI
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 04, 2025, 11:37 AM
NexImmune Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.42M | 4.47M | 3.2M | 9M | 16.28M | 22.32M | 34.64M | 45.86M | 40.64M | 24.5M | 30.33M | 37.26M | 63.82M | 118.1M |
Short-Term Investments | n/a | n/a | 1.44M | n/a | n/a | n/a | n/a | n/a | 12.48M | 40.51M | 51.49M | 55.99M | 38.98M | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.63M | 1.71M | 1.79M | n/a | 300.2K | 190.58K | 264.97K | 72.08K | 146.01K | 593.52K | 324.1K | 1.53M | 53.37K | 23.37K |
Receivables | n/a | n/a | n/a | 39.01K | 66.93K | 83.82K | 74.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | -39.01K | 1.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 235.64K | 1.07M | 235.25K | 127.38K | 304.93K | 324.54K | 456.92K | 41.39K | 70.4K | 194.53K | 99.19K | 31.48K | 60.13K | 67.5K |
Total Current Assets | 3.13M | 6.04M | 5.4M | 10.32M | 18.5M | 25.4M | 37.37M | 52M | 59.59M | 71.9M | 86.28M | 98.73M | 111.19M | 122.96M |
Property-Plant & Equipment | 1.11M | 1.24M | 1.4M | 4.24M | 4.67M | 5.07M | 5.43M | 5.6M | 5.93M | 5.82M | 4.43M | 4.29M | 4.15M | 3.58M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.73M | 2.95M | 3.19M | 4.24M | 4.97M | 5.26M | 5.69M | 5.67M | 6.08M | 6.41M | 4.75M | 5.81M | 4.2M | 3.61M |
Total Assets | 5.86M | 8.99M | 8.59M | 14.56M | 23.47M | 30.66M | 43.06M | 57.67M | 65.67M | 78.31M | 91.03M | 104.54M | 115.39M | 126.57M |
Account Payables | 1.28M | 771.61K | 1.34M | 737.49K | 582.51K | 650.57K | 2.38M | 1.26M | 1.65M | 2.01M | 1.05M | 3.5M | 2.17M | 2.41M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -843.62K |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 843.62K | n/a |
Other Current Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 843.62K |
Total Current Liabilities | 4.74M | 4.63M | 5.08M | 6.2M | 6.27M | 6.79M | 10.33M | 9.39M | 9.11M | 7.09M | 7.22M | 7.43M | 5.48M | 6.09M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 204.17K | 1.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 55.58K | n/a | n/a | 11.76K |
Total Long-Term Liabilities | 204.17K | 1.39M | n/a | 102.83K | 203.89K | 300.22K | 425.77K | 564.5K | 699.56K | 829.44K | 55.58K | n/a | n/a | 11.76K |
Total Liabilities | 4.94M | 6.02M | 5.08M | 6.31M | 6.47M | 7.09M | 10.76M | 9.96M | 9.81M | 7.92M | 7.27M | 7.43M | 5.48M | 6.1M |
Total Debt | n/a | n/a | 68.81K | 604.64K | 749.17K | 888.16K | 1.02M | 1.16M | 1.29M | 1.42M | n/a | n/a | 843.62K | 843.62K |
Common Stock | 139K | 224.33K | 2.65K | 2.65K | 2.61K | 2.61K | 2.61K | 2.61K | 2.29K | 2.28K | 2.28K | 2.27K | 2.26K | 2.26K |
Retained Earnings | -228M | -225.67M | -222.59M | -217.24M | -207.38M | -199.81M | -190.25M | -173.36M | -158.63M | -142.77M | -127.74M | -112.22M | -97.57M | -85.39M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.34K | -20.58K | 3.01K | 702.00 | -2.92K | -1.6M |
Shareholders Equity | 920.54K | 2.97M | 3.51M | 8.25M | 17M | 23.58M | 32.3M | 47.72M | 55.85M | 70.39M | 83.76M | 97.11M | 109.91M | 120.46M |
Total Investments | n/a | n/a | 1.44M | n/a | n/a | n/a | n/a | n/a | 12.48M | 40.51M | 51.49M | 55.99M | 38.98M | n/a |